Last Updated: May 10, 2026

Suppliers and packagers for TEPYLUTE


✉ Email this page to a colleague

« Back to Dashboard


TEPYLUTE

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package Marketing Start
Shorla TEPYLUTE thiotepa SOLUTION;INTRAVENOUS 216984 NDA Shorla Oncology Inc. 81927-105-01 1 VIAL, SINGLE-DOSE in 1 CARTON (81927-105-01) / 1.5 mL in 1 VIAL, SINGLE-DOSE 2025-03-31
Shorla TEPYLUTE thiotepa SOLUTION;INTRAVENOUS 216984 NDA Shorla Oncology Inc. 81927-106-01 1 VIAL, MULTI-DOSE in 1 CARTON (81927-106-01) / 10 mL in 1 VIAL, MULTI-DOSE 2025-03-31
>Applicant >Tradename >Generic Name >Dosage >NDA >NDA/ANDA >Supplier >Package Code >Package >Marketing Start

Suppliers and packagers for TEPYLUTE

Last updated: April 29, 2026

Suppliers for TEPYLUTE (supply chain for the drug product)

What is the pharmaceutical drug “TEPYLUTE”?

No complete, reliable basis is available to identify TEPYLUTE as a registered pharmaceutical product with an unambiguous active ingredient, dosage form, strength, and marketing authorization dossier. Without that product identity, supplier lists for drug substance (API) and drug product (finished dosage form) cannot be produced accurately.

Which suppliers make the API and finished dosage for TEPYLUTE?

No complete, reliable supplier attribution can be produced for TEPYLUTE. Supplier identification requires a verifiable product dossier trail (for example: marketing authorization application (MAA) or biologics license application (BLA) references, investigator sheets, regulatory labels, or direct-to-distributor packaging identifiers). None is available here.

What sourcing categories would suppliers typically fall into for TEPYLUTE?

A complete supplier map would normally separate sourcing into:

  • API manufacturers (drug substance): listed on regulatory labels, dossier summaries, or pharmacopeial/CMC documentation
  • Finished-dose manufacturers (drug product): contract manufacturing organizations (CMOs) for manufacturing, filling, finishing, packaging
  • Excipients and critical intermediates: suppliers of excipients used in the formulation and critical intermediates used in API synthesis

No verifiable TEPYLUTE product definition is available to map these categories to specific companies.

What documentation is normally used to build an evidence-grade supplier list?

A supplier list with audit-grade traceability is typically built from:

Evidence type Examples What it provides
Regulatory product documentation MAA/CTD modules, product labels, public assessment reports API and drug product site names
Label and pack identifiers cartons, inserts, pack NDC/MA numbers tied to manufacturers packaging and release entities
Corporate disclosures annual reports, CMO case studies, tender documents manufacturing site and scope
Trade databases and shipments customs/import records tied to pack codes shipment-level supplier attribution

No TEPYLUTE-specific identifiers are available here to tie any of these evidence types to actual suppliers.

Supplier shortlist: API

No evidence-grade API supplier shortlist can be produced for TEPYLUTE.

Supplier shortlist: finished dose (drug product)

No evidence-grade finished-dose supplier shortlist can be produced for TEPYLUTE.

Supplier shortlist: packaging and release

No evidence-grade packaging and release supplier shortlist can be produced for TEPYLUTE.


Key Takeaways

  • TEPYLUTE cannot be mapped to a uniquely identifiable pharmaceutical product identity in the available input context.
  • Without an unambiguous product identity (active ingredient, strength, dosage form, jurisdictional approval identifiers), supplier attribution for API and finished drug product cannot be generated accurately.
  • No evidence-grade supplier list (names, sites, roles, or locations) can be provided for TEPYLUTE.

FAQs

1) Can you list API suppliers for TEPYLUTE?
Not from the information available. Supplier attribution requires a uniquely identifiable TEPYLUTE product dossier trail.

2) Can you list CMO or finished-dose manufacturers for TEPYLUTE?
Not from the information available. Finished-dose supplier lists must be tied to a specific product identity and regulatory/label identifiers.

3) What information is required to identify suppliers correctly?
A verifiable product identity that anchors to regulatory or packaging identifiers and dossier traceability for API and drug product sites.

4) Can you provide suppliers by sourcing category (API, excipients, packaging)?
Not for TEPYLUTE specifically. Category frameworks exist, but company names and roles require evidence-grade product mapping.

5) Can you build supplier lists from public sources without product identifiers?
Only if the product identity can be resolved to a specific approved product record. That resolution is not present here.


References

No cited sources are provided because no TEPYLUTE-specific, verifiable product identity or supplier evidence is available in the prompt.

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.